Gestational diabetes affects up to 9.2% of pregnancies and requires careful blood glucose management to prevent complications. That’s why implementing remote patient monitoring should be standard practice for expectant mothers with diabetes.
Traditionally, gestational diabetes is monitored by periodic office finger sticks. However, this approach lacks real-time visibility. Blood sugar highs and lows between visits can go unseen, leading to emergencies if left untreated. Remote monitoring can catch these lows and highs before they become emergencies, allowing physicians to intervene.
Systems like continuous glucose monitors (CGMs) allow pregnant women and their providers to view real-time blood sugar readings on demand through their smartphone. Unexpected spikes or dips are communicated instantly, enabling quick clinical interventions like diet adjustments or insulin dosing.
In addition, the 24/7 CGM data enables doctors to better analyze the impacts of exercise, nutrition, and medication on glucose control from afar. This supports more informed therapy optimizations to keep expectant mothers in tight glycemic control without frequent office visits.
Most importantly, the enhanced visibility and glycemic control achieved through remote monitoring significantly reduces risks of maternal complications like preeclampsia. It also lowers risks of neonatal complications like excess growth and hypoglycemia.
For women with gestational diabetes, remote monitoring delivers vital data for tight blood sugar management and helps mitigate emergencies between prenatal visits. The improved outcomes and convenience demonstrate why remote glucose monitoring should be the standard of care.